{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T13:30:21Z","timestamp":1688563821227},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.2515\/therapie:2004062","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T07:32:36Z","timestamp":1174030356000},"page":"329-336","source":"Crossref","is-referenced-by-count":1,"title":["Transposition de la Directive Essais Cliniques"],"prefix":"10.1016","volume":"59","author":[{"given":"Chantal","family":"B\u00e9lorgey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Pl\u00e9tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Goehrs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-H.","family":"Bertoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Brion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Buntix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Caplain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Caulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Courcier-Duplantier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Daurat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Demarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Diquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Echemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lamarque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Libersa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Patat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Pinquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Reynier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sibenaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Warot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2004062_bb0775","unstructured":"Directive 2001\/20\/CE du parlement europ\u00e9en et du conseil du 4 avril 2001. J.O.C.E. L121\/34\u201344, 01\/05\/2001 [online]. Available from URL: http:\/\/pharmacos.eudra.org\/F2\/eudralex\/vol-1\/new_v1\/Dir2001-20."},{"key":"10.2515\/therapie:2004062_bb0780","unstructured":"Code de la Sant\u00e9 Publique. 1\u00e8re partie, livre II bis. Protection des personnes qui se pr\u00eatent \u00e0 des recherches biom\u00e9dicales (Loi Huriet-S\u00e9rusclat n\u00b0 88-1138 du 20\/12\/1988 modifi\u00e9e) [online]. Available from URL: http:\/\/www.inserm.fr\/ethique\/Lois.nsf\/0\/d7b21010506d792bc125692f00582246?.OpenDocument [Accessed 2004 Jul 11]"},{"key":"10.2515\/therapie:2004062_bb0785","unstructured":"Detailed guidance for the request for authorisation of a clinical trial on a medicinal product for human use to the competent authorities, notification of substantial amendments and declaration of the end of the trial (as required by Article 9 (8) of Directive 2001\/20\/EC) [online]. Available from URL: http:\/\/pharmacos.eudra.org\/F2\/pharmacos\/docs\/Doc2003\/april\/cp-guidance-ca_230403.pdf [Accessed 2004 Jul 11]"},{"key":"10.2515\/therapie:2004062_bb0790","first-page":"341","article-title":"et les participants de la table ronde n\u00b0 2 de Giens XVI. Difficult\u00e9s \u00e0 la r\u00e9alisation des essais cliniques en France","volume":"56","author":"Zannad","year":"2001","journal-title":"Th\u00e9rapie"},{"key":"10.2515\/therapie:2004062_bb0795","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2515\/therapie:2003045","article-title":"Attractivit\u00e9 de la France pour les essais cliniques : \u00e9valuation par les laboratoires promoteurs","volume":"58","author":"D\u2019Enfert","year":"2003","journal-title":"Th\u00e9rapie"},{"key":"10.2515\/therapie:2004062_bb0800","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2515\/therapie:2003089","article-title":"Les enjeux de la transposition de la Directive europ\u00e9enne 2001\/20\/CE dans les principaux Etats Membres","volume":"58","author":"Libersa","year":"2003","journal-title":"Th\u00e9rapie"},{"key":"10.2515\/therapie:2004062_bb0805","unstructured":"EMEA (The European Agency for the Evaluation of Medicinal Products). ICH topic E6, guideline for good clinical practice. Step 5, consolidated guideline 1.5.96. Note for guidance on good clinical practice (CPMP ICH\/135\/95) [online]. Available from URL: http:\/\/www.emea.eu.int\/pdfs\/human\/ich\/013595en.pdf [Accessed 2004 Jul 11]"},{"key":"10.2515\/therapie:2004062_bb0810","unstructured":"EMEA (The European Agency for the Evaluation of Medicinal Products). ICH topic M4, common technical document for the registration for human use: organisation of common technical document. Clinical overview, clinical summary (module 2). Clinical study reports (module 5). Step 4, 09. 11. 2000 [online]. Available from URL: http:\/\/www.emea.eu.int\/pdfs\/human\/ich\/288799enm.pdf [Accessed 2004 Jul 11]"},{"key":"10.2515\/therapie:2004062_bb0815","unstructured":"Content and format of investigational new drug applications (INDs) for phase I studies of drugs, including well-characterized, therapeutic, biotechnology, derived products. Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Food and Drug Administration, Nov 1995 [online]. Available from URL: http:\/\/www.fda.gov\/cder\/guidance\/clin2.pdf [Accessed 2004 Jul 11]"},{"key":"10.2515\/therapie:2004062_bb0820","unstructured":"EMEA (The European Agency for the Evaluation of Medicinal Products). ICH topic M3, non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals. ICH step 5: note for guidance on non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals (CPMP ICH\/286\/95) 11.2000 [online]. Available from URL: http:\/\/www.emea.eu.int\/pdfs\/human\/ich\/028695en.pdf [Accessed 2004 July 11]"},{"key":"10.2515\/therapie:2004062_bb0825","unstructured":"Detailed guidance on the collection, verification and presentation of adverse reaction reports arising from trials on medicinal products for human use (as required by Article 18 of Directive 20014\/20\/EC). Apr, 2004 [online]. Available from URL: http:\/\/pharmacos.eudra.org\/F2\/pharmacos\/docs\/Doc2003\/april\/cp-guidance-swar-160403.pdf [Accessed 2004 Jul 11]"},{"key":"10.2515\/therapie:2004062_bb0830","unstructured":"Loi no 2002-303 du 4 mars 2002 relative aux droits des malades et \u00e0 la qualit\u00e9 du syst\u00e8me de sant\u00e9 [online]. Avialable from URL: http:\/\/www.legifrance.gouv.fr\/WAspad\/UnTexteDeJorf?.numjo=MESX0100092L [Accessed 2004 Jul 11]"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716302074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716302074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T06:44:51Z","timestamp":1554273891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716302074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0040595716302074"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2004062","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}